Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Mar-24 4:01 PM View:  | Nantahala Capital Managemen... 10% Owner | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Mar-24 | Exercise (in-the money or at-the-money) | 755,000 | $5.00 | $3,775,000.00 | 61% 1.24M to 1.99M | |
| 12-Mar-24 6:39 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 12-Mar-24 | Grant | 8,000 | $1.12 | $8,995.20 | 5% 162.81K to 170.81K | |
| 12-Mar-24 6:39 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Mar-24 | Grant | 1,000 | $1.12 | $1,115.00 | < 1% 161.81K to 162.81K | |
| 04-Mar-24 8:53 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-24 | Payment of Exercise | 1,623 | $1.30 | $2,109.90 | (< 1%) 163.43K to 161.81K | |
| 04-Mar-24 8:57 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-24 | Payment of Exercise | 406 | $1.30 | $527.80 | (1%) 31.82K to 31.41K | |
| 04-Mar-24 8:55 PM View: | Palmer Pamela P Chief Medical Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-24 | Payment of Exercise | 450 | $1.30 | $585.00 | (< 1%) 59.6K to 59.15K | |
| 04-Mar-24 8:54 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-24 | Payment of Exercise | 558 | $1.30 | $725.40 | (1%) 38.29K to 37.73K | |
| 27-Feb-24 9:04 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 14-Feb-24 | Grant | 14,667 | -- | -- | 86% 17.15K to 31.82K | |
| 27-Feb-24 9:06 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 14-Feb-24 | Grant | 18,000 | -- | -- | 51% 35.34K to 53.34K | |
| 27-Feb-24 8:58 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 14-Feb-24 | Grant | 58,667 | -- | -- | 62% 94.76K to 153.43K | |
| 27-Feb-24 9:01 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 14-Feb-24 | Grant | 18,000 | -- | -- | 89% 20.29K to 38.29K | |
| 13-Feb-24 9:46 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-24 | Payment of Exercise | 809 | $1.10 | $889.90 | (5%) 17.96K to 17.15K | |
| 13-Feb-24 9:44 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-24 | Payment of Exercise | 801 | $1.10 | $881.10 | (2%) 36.15K to 35.34K | |
| 13-Feb-24 9:42 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-24 | Payment of Exercise | 895 | $1.10 | $984.50 | (4%) 21.19K to 20.29K | |
| 13-Feb-24 9:40 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-24 | Payment of Exercise | 3,723 | $1.10 | $4,095.30 | (4%) 98.48K to 94.76K | |
| 13-Feb-24 9:42 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-24 | Payment of Exercise | 895 | $1.10 | $984.50 | (4%) 22.08K to 21.19K | |
| 13-Feb-24 9:40 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-24 | Payment of Exercise | 3,320 | $1.10 | $3,652.00 | (3%) 101.81K to 98.48K | |
| 13-Feb-24 9:46 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-24 | Payment of Exercise | 809 | $1.10 | $889.90 | (4%) 18.77K to 17.96K | |
| 13-Feb-24 9:44 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-24 | Payment of Exercise | 801 | $1.10 | $881.10 | (2%) 36.95K to 36.15K | |
| 23-Jan-24 5:22 PM View: | Jain Abhinav Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 22-Jan-24 | Grant | 871 | -- | -- | 100% 0 to 0.87K | |
| 14-Dec-23 8:11 AM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 13-Dec-23 | Purchase | 10,000 | $0.73 | $7,268.00 | 11% 91.81K to 101.81K | |
| 13-Dec-23 4:21 PM View: | Rosen Howard B Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 12% 4.71K to 5.29K | |
| 13-Dec-23 4:34 PM View: | Afable Richard Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 31% 1.89K to 2.47K | |
| 13-Dec-23 4:19 PM View: | Adams Adrian Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 5% 10.59K to 11.17K | |
| 13-Dec-23 4:35 PM View: | Hoffman Stephen J Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 32% 1.84K to 2.42K | |
| 13-Dec-23 4:25 PM View: | Bozilenko Marina Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 29% 2.02K to 2.61K | |
| 13-Dec-23 4:23 PM View: | Church Jill Marie Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 38% 1.52K to 2.11K | |
| 13-Dec-23 4:33 PM View: | Wan Mark A Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 32% 1.84K to 2.42K | |
| 11-Sep-23 7:13 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Sep-23 | Purchase | 10,000 | $0.80 | $7,950.00 | 12% 81.81K to 91.81K | |
| 25-Aug-23 4:45 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 25-Aug-23 | Sale | 7,442 | $1.09 | $8,104.34 | (19%) 38.2K to 30.75K | |
| 25-Aug-23 4:45 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 24-Aug-23 | Private Sale | 9,514 | $1.17 | $11,131.40 | (20%) 47.71K to 38.2K | |
| 06-Mar-23 4:45 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-23 | Payment of Exercise | 398 | $1.31 | $521.38 | (2%) 19.17K to 18.77K | |
| 06-Mar-23 4:40 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-23 | Payment of Exercise | 1,703 | $1.31 | $2,230.93 | (3%) 65.54K to 63.84K | |
| 06-Mar-23 4:44 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-23 | Payment of Exercise | 570 | $1.31 | $746.70 | (1%) 43.88K to 43.31K | |
| 06-Mar-23 4:42 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 03-Mar-23 | Payment of Exercise | 510 | $1.31 | $668.10 | (2%) 22.59K to 22.08K | |
| 14-Feb-23 10:00 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-23 | Payment of Exercise | 1,017 | $1.68 | $1,708.56 | (2%) 44.9K to 43.88K | |
| 14-Feb-23 10:00 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-23 | Payment of Exercise | 873 | $1.68 | $1,466.64 | (4%) 23.46K to 22.59K | |
| 14-Feb-23 10:00 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-23 | Payment of Exercise | 776 | $1.68 | $1,303.68 | (4%) 19.95K to 19.17K | |
| 14-Feb-23 4:19 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 11-Feb-23 | Payment of Exercise | 3,321 | $1.68 | $5,579.28 | (5%) 68.86K to 65.54K | |
| 14-Feb-23 4:19 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-23 | Grant | 19,500 | -- | -- | 40% 49.36K to 68.86K | |
| 14-Feb-23 10:00 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-23 | Grant | 6,125 | -- | -- | 16% 38.78K to 44.9K | |
| 14-Feb-23 10:00 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-23 | Grant | 5,875 | -- | -- | 33% 17.59K to 23.46K | |
| 14-Feb-23 10:00 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Feb-23 | Grant | 4,875 | -- | -- | 32% 15.07K to 19.95K | |
| 08-Feb-23 4:51 PM View: | Dasu Badri N Chief Engineering Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-23 | Payment of Exercise | 458 | $2.02 | $925.16 | (3%) 15.53K to 15.07K | |
| 08-Feb-23 4:42 PM View: | Angotti Vincent J. Chief Executive Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-23 | Payment of Exercise | 1,982 | $2.02 | $4,003.64 | (4%) 51.34K to 49.36K | |
| 08-Feb-23 4:46 PM View: | Palmer Pamela P Chief Medical Officer Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-23 | Payment of Exercise | 681 | $2.02 | $1,375.62 | (2%) 39.46K to 38.78K | |
| 08-Feb-23 4:48 PM View: | Asadorian Raffi Chief Financial Officer | AcelRx Pharmaceuticals, Inc. (TLPH) | 06-Feb-23 | Payment of Exercise | 617 | $2.02 | $1,246.34 | (3%) 18.21K to 17.59K | |
| 15-Jul-22 7:31 PM View: | Adams Adrian Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Jul-22 | Grant | 15,500 | -- | -- | 8% 196.25K to 211.75K | |
| 15-Jul-22 7:33 PM View: | Bozilenko Marina Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Jul-22 | Grant | 15,500 | -- | -- | 62% 25.0K to 40.5K | |
| 15-Jul-22 7:29 PM View: | Hoffman Stephen J Director | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Jul-22 | Grant | 15,500 | -- | -- | 73% 21.25K to 36.75K |
